The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a ...
Laws focused lowering drug prices have expanded in 15 states, with new boards and payment limits shaping affordability since 2017.
The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
The upheaval at the FDA appears to be taking a toll on the pharmaceutical industry, according to a new analysis of key agency ...
WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to ...
Stocktwits on MSN
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options
Sensei Biotherapeutics, Inc. (SNSE) on Thursday said that its Board of Directors has determined to discontinue development of ...
Drugmaker Pfizer on Friday sued obesity-drug developer Metsera and Novo Nordisk, seeking to block Metsera from terminating ...
Neuphoria added it has an ongoing partnership with Merck & Co. under which MK-1167 is currently being evaluated in a Merck-led Phase 2 trial in Alzheimer's disease. Through the partnership, Neuphoria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback